These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10499198)

  • 1. [Dyslipoproteinemia of diabetes: fibrates or statins?].
    Moulin P
    Diabetes Metab; 1999 Sep; 25(3):270-4. PubMed ID: 10499198
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug therapy for dyslipoproteinaemia.
    Bain SC; Barnett AH; Jones AF
    Diabet Med; 1990 Dec; 7(10):931-4. PubMed ID: 2149695
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of dyslipidemias].
    Fonda M; Cattin L; Guarnieri G
    Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins and fibrates in the management of diabetic dyslipidemia.
    Durrington P
    Diabet Med; 1997 Jul; 14(7):513-6. PubMed ID: 9223386
    [No Abstract]   [Full Text] [Related]  

  • 5. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 6. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I; Krone W
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of dyslipidemias and its benefits].
    Taskinen MR
    Duodecim; 1999; 115(10):1138-44. PubMed ID: 11877853
    [No Abstract]   [Full Text] [Related]  

  • 8. [Which antilipemic agent when?].
    Schwandt P
    Internist (Berl); 1989 Sep; 30(9):625. PubMed ID: 2807786
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the effects of tiadenol in various types of dyslipidemia].
    Saettone G; Cazzani E; Romanò M; Muzio L
    Clin Ter; 1982 May; 101(4):387-93. PubMed ID: 7105643
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antilipemic drugs].
    Schwandt P
    Med Monatsschr Pharm; 1980 Oct; 3(10):302-5. PubMed ID: 7007844
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dyslipidemias and diabetes mellitus].
    Pometta D
    Journ Annu Diabetol Hotel Dieu; 1989; ():47-54. PubMed ID: 2668624
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is it necessary to systematically treat diabetics with statins?].
    Vergès B
    Journ Annu Diabetol Hotel Dieu; 2001; ():189-95. PubMed ID: 11565462
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ezetimib].
    Meyer Zu Schwabedissen H; Kroemer HK
    Dtsch Med Wochenschr; 2004 Sep; 129(39):2038-40. PubMed ID: 15386207
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diabetic dyslipoproteinemia: physiopathological bases and treatment prospects].
    Demant T
    Fortschr Med Orig; 2001; 119(1):37-40. PubMed ID: 11935656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drugs in hyperlipidemia].
    Stuyt PM
    Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1554-8. PubMed ID: 3670435
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dyslipoproteinemia and diabetes mellitus].
    Vaverková H
    Vnitr Lek; 2000 Sep; 46(9):532-8. PubMed ID: 11344647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the antilipemic effect of etofibrate (Lipo-Merz)].
    Słowińska R; Bochenek W; Unlot J
    Pol Tyg Lek; 1983 Apr; 38(17):529-32. PubMed ID: 6356087
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacotherapy of hyperlipoproteinemias: indications, mechanisms of action, effectiveness and side effects].
    Schernthaner G; Woschnagg H
    Wien Med Wochenschr; 1990 Feb; 140(3):64-75. PubMed ID: 2180212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of action of drugs affecting lipid metabolism].
    Rossini L
    Minerva Med; 1975 Oct; 66(66):3458-68. PubMed ID: 1178137
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid disturbances in chronic renal failure--patomechanisms and treatment.
    Rutkowski B; Chmielewski M
    Rocz Akad Med Bialymst; 2004; 49():139-44. PubMed ID: 15631330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.